GRDN - NYSE
Guardian Pharmacy Services, Inc.
$39.14
-0.31%Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
At a Glance
Live Snapshotgrdn
Total Equity
Last Annual Value
217.92M
3-Year CAGR
42%
5-Year CAGR
27%
10-Year CAGR
14%
Guardian Pharmacy Services, Inc. Competitors Analysis of Total Equity
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Guardian Pharmacy Services, Inc. NYSE:GRDN | 217.92M | 53.8% | 32.5% | N/A | |
 National HealthCare Corporation AMEX:NHC | 1.07B | 5.7% | 3.4% | 5.5% | |
865.85M | 0.7% | -0.7% | -10.9% | ||
 QuidelOrtho Corporation NASDAQ:QDEL | 1.92B | -27.3% | -0.1% | 25.3% | |
 Nuvation Bio Inc. NYSE:NUVB | 305.72M | -20.4% | -16.3% | N/A | |
 Janux Therapeutics, Inc. NASDAQ:JANX | 956.82M | 40.6% | 21.2% | N/A | |
 Twist Bioscience Corporation NASDAQ:TWST | 472.96M | -8.8% | -4.0% | N/A | |
 Edgewise Therapeutics, Inc. NASDAQ:EWTX | 522.26M | 17.9% | 13.7% | N/A | |
 PROCEPT BioRobotics Corporation NASDAQ:PRCT | 365.87M | 9.2% | 6.5% | N/A | |
 10x Genomics, Inc. NASDAQ:TXG | 796.33M | 2.4% | -0.5% | N/A |
Guardian Pharmacy Services, Inc. Fair Value Envelope
Related Guides
Continue your GRDN research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.